15473585

Source:http://linkedlifedata.com/resource/pubmed/id/15473585

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007113, umls-concept:C0442027, umls-concept:C0445204, umls-concept:C0521115, umls-concept:C0920321, umls-concept:C1442162, umls-concept:C1442989, umls-concept:C1446539, umls-concept:C1522449, umls-concept:C1550718
pubmed:issue	10
pubmed:dateCreated	2004-10-11
pubmed:abstractText	Preoperative radiotherapy is standard treatment for rectal cancer and is often combined with 5-fluorouracil-based chemotherapy. UFT, a new oral 5FU derivative, given daily during a course of radiotherapy mimics the effect of continuous-infusion 5FU.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100930740
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Folic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Leucovorin, http://linkedlifedata.com/resource/pubmed/chemical/Tegafur, http://linkedlifedata.com/resource/pubmed/chemical/Uracil
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1565-1088
pubmed:author	pubmed-author:CataneRaphaelR, pubmed-author:ElkayamRuthR, pubmed-author:KollerMosheM, pubmed-author:KundelYuliaY, pubmed-author:PfefferM RaphaelMR, pubmed-author:SymonZviZ, pubmed-author:ZehaviMeirM, pubmed-author:ZmoraOdedO
pubmed:issnType	Print
pubmed:volume	6
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	595-8
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:15473585-Adenocarcinoma, pubmed-meshheading:15473585-Administration, Oral, pubmed-meshheading:15473585-Adult, pubmed-meshheading:15473585-Aged, pubmed-meshheading:15473585-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15473585-Colectomy, pubmed-meshheading:15473585-Combined Modality Therapy, pubmed-meshheading:15473585-Female, pubmed-meshheading:15473585-Folic Acid, pubmed-meshheading:15473585-Humans, pubmed-meshheading:15473585-Leucovorin, pubmed-meshheading:15473585-Male, pubmed-meshheading:15473585-Maximum Tolerated Dose, pubmed-meshheading:15473585-Middle Aged, pubmed-meshheading:15473585-Neoadjuvant Therapy, pubmed-meshheading:15473585-Neoplasm Staging, pubmed-meshheading:15473585-Radiotherapy, pubmed-meshheading:15473585-Rectal Neoplasms, pubmed-meshheading:15473585-Tegafur, pubmed-meshheading:15473585-Treatment Outcome, pubmed-meshheading:15473585-Uracil
pubmed:year	2004
pubmed:articleTitle	A phase I study of oral UFT given concomitantly with standard preoperative radiotherapy for rectal cancer.
pubmed:affiliation	Oncology Institute, Sheba Medical Center, Tel Hashomer, Israel. raphipf@sheba.health.gov.il
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Research Support, Non-U.S. Gov't, Clinical Trial, Phase I